|1st September 2020||Inc. Innoviva,||4,672,897||Open or private purchase||$2.68||$12,499,999.48|
|11th June 2020||Inc. Innoviva,||12,677,490||Open or private purchase||$2.50||$31,693,725.00|
|27th March 2020||Inc. Innoviva,||7,717,661||Open or private purchase||$2.87||$22,149,687.07|
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.
. Develops and commercializes novel bacteriophage-based therapeutics. Developing and commercializing novel bacteria-based therapies for cancer and other diseases.